Combined endocardial and epicardial radiofrequency ablation of right and left atria in the treatment of atrial fibrillation

Citation
Js. Raman et al., Combined endocardial and epicardial radiofrequency ablation of right and left atria in the treatment of atrial fibrillation, ANN THORAC, 72(3), 2001, pp. S1096-S1099
Citations number
13
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Journal title
ANNALS OF THORACIC SURGERY
ISSN journal
00034975 → ACNP
Volume
72
Issue
3
Year of publication
2001
Pages
S1096 - S1099
Database
ISI
SICI code
0003-4975(200109)72:3<S1096:CEAERA>2.0.ZU;2-K
Abstract
Background. The maze procedure and its modifications have been successful i n treating atrial fibrillation (AF), at the expense of longer procedure tim es and increased morbidity. This study evaluated the early results of using radiofrequency ablation as a surgical adjunct in treating AF. Methods. Twenty-six patients, with established or frequent intermittent AF, who were undergoing various cardiac surgical procedures, were enrolled. Du ring their operations, the patients underwent intraoperative left and right atrial radiofrequency ablation lesions using a handheld flexible probe. Pa tients were followed up with echocardiography and Holter monitoring. Results. All 26 patients were weaned off cardiopulmonary bypass in sinus rh ythm. There were 2 early noncardiac deaths in high-risk patients; 23 surviv ing patients (95%) remained in sinus rhythm at a mean follow-up of 175 days (range 96 to 400 days). Three patients were defibrillated into sinus rhyth m 30, 40, and 60 days after their operation. Test epicardial lesions on the right atrial appendage in 12 patients showed full-thickness coagulation of tissue in 10 (83%). Conclusions. A combined endocardial and epicardial set of radiofrequency le sions in both atria abolished AT in most patients at 6 months and facilitat ed easy conversion of recurrent AF into sinus rhythm. The transmural nature of the epicardial lesions has implications for further development. (C) 20 01 by The Society of Thoracic Surgeons.